Related Experiment Video
Updated: Jul 7, 2026

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
Published on: September 16, 2015
Keeping the promise: a critique of the current state of microdosing research
Rotem Petranker1, Thomas Anderson2, Emily C Fewster3
1Department of Psychology, Neuroscience and Behaviour, Hamilton, ON, Canada.
Introduction:
The practice of taking small, sub-hallucinogenic doses of psychedelics, known as microdosing, has exploded in popularity over the last decade. Users claim benefits ranging from improved mood and enhanced creativity to an increased sense of meaning and connectedness in life. While research on microdosing is still lagging behind the shift in public opinion, several papers have been published in the last five years which attempted to assess the effects of microdosing.
Methods:
This review paper aimed to critically analyze the research practices used in the recent wave of microdosing research: We reviewed 15 papers published before the closing date of this review in March 2022.
Results:
Our review concludes that it is premature to draw any conclusions about the efficacy or safety of microdosing since the research quality cannot be considered confirmatory.
Discussion:
We propose some potential causes for the current state of the literature and some suggestions for how these causes may be ameliorated.
Related Concept Videos
The Placebo Effect
Drug Regulation
Dose-Response Relationship: Overview
Dose-Response Relationship: Potency and Efficacy
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...

